Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BREXAFEMME ® safely and effectively. See full prescribing information for BREXAFEMME ® . BREXAFEMME ® (ibrexafungerp tablets ) , for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
BREXAFEMME ® is indicated in adult and post-menarchal pediatric females for: ● Treatment of vulvovaginal candidiasis (VVC) ● Reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC). If specimens for fungal culture are obtained prior to therapy, antifungal therapy may be instituted before the results of the cultures are known. However, once these results become available, antifungal therapy should be adjusted accordingly.
- generic_name
- ibrexafungerp
- product_names
- ibrexafungerp
- ndc
- 75788-115, 75788-115-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en